To coincide with the 9th International AIDS Society Conference (IAS) taking place in Paris from 23-26 July 2017, Unitaid and the Global Fund are highlighting France’s role as a major player in global health and its continuing engagement in the fight against AIDS, tuberculosis and malaria.
France is at the forefront of international cooperation and is driving innovation, in particular through research done by the ANRS (French Agency for Research on AIDS and Viral Hepatitis), and through its support for universal access to treatment. The country’s commitment also translates into significant contributions to two key organizations: Unitaid and the Global Fund to Fight AIDS, Tuberculosis and Malaria, which were established to accelerate the end of the three diseases as epidemics.
France is the Global Fund’s largest European donor and second-largest overall. As a founding member of Unitaid and its largest donor, France’s contributions account for more than half of the organization’s total budget.
Unitaid and the Global Fund have shown that their efforts to combat HIV, tuberculosis and malaria are complementary.
By investing in the most promising innovations in prevention, diagnosis and treatment, Unitaid is speeding up adoption of the most effective and least expensive tools and solutions, increasing the impact of Global Fund-supported programs. In addition, one euro invested by Unitaid yields a return of 7 to 10 times the initial investment.
Today, 80 percent of antiretroviral drugs for HIV used in Africa were introduced thanks to the work of Unitaid, which has helped lower the price of these drugs significantly (80 euros per person per year), and to the Global Fund’s large‑scale delivery efforts. The new generation of drugs are now available in Africa, thanks to the joint efforts of ANRS and Unitaid, and has been made more widely available through Global Fund-supported programs.
Putting an end to the AIDS, tuberculosis and malaria epidemics is possible – with help from France. By working together to step up our efforts, we can help protect the 3.2 billion people still exposed to the risk of malaria, halt the 28,000 daily new cases of tuberculosis and treat the 18 million people living with HIV and awaiting care.